Yates AG, Kislitsyna E, Alfonso Martin C, Zhang J, Sewell AL, Goikolea-Vives A, Cai V, Alkhader LF, Skaland A, Hammond B, Dimitrova R, Batalle D, Fernandes C, Edwards AD, Gressens P, Thornton C, Stolp HB (2022) Montelukast reduces grey matter abnormalities and functional deficits in a mouse model of inflammation-induced encephalopathy of prematurity
(See all compounds classified as Enzyme Inhibitors.) V03AB17 V - Various V03 - All other therapeutic products V03A - All other therapeutic products V03AB - Antidotes V03AB17 - Methylthioninium chloride V - Various V04 - Diagnostic agents V04C - Other diagnostic agents V04CG - Tests for gastric secretion V04CG05 - Methylthioninium chloride Route of Elimination Excreted in urine and bile
Lotions enriched with GHK-Cu can also aid in overall skin hydration and elasticity
Formulated for maximum stability, purity, and rapid cellular bioavailability